Enhanced Cardiotoxicity in Rabbits Treated with Verapamil and Adriamycin
- 1 January 1987
- journal article
- research article
- Published by S. Karger AG in Oncology
- Vol. 44 (5) , 302-306
- https://doi.org/10.1159/000226499
Abstract
Verapamil, a calcium channel blocker, reduces resistance of some tumors to Adriamycin by inhibiting Adriamycin efflux from resistant cells. This study shows that rabbits given 7 mg/kg of Adriamycin and 0.8 mg/kg of verapamil died earlier with functional and morphological cardiac abnormalities than rabbits given Adriamycin alone. Rabbits that were given verapamil and died peracutely had higher concentrations of Adriamycin in the myocardium. The relatively high dose of Adrimaycin was expected to produce cardiotoxicity in rabbits within a matter of days. However, peracute death (within hours) in rabbits given the same dose of Adriamycin but with veparamil treatment was unexpected. These results suggest that combining Adriamycin with veparamil increases early cardiac toxicity. Therefore, clinical use of this combination should be approached cautiously until the interactions, including the possibility for enhanced normal tissue damage, are fully understood.Keywords
This publication has 11 references indexed in Scilit:
- EFFECTS OF VERAPAMIL ON DAUNOMYCIN CELLULAR RETENTION AND CYTO-TOXICITY IN P388 LEUKEMIC-CELLS1984
- Verapamil protection of ischemic isolated rabbit heart: Dependence on pretreatmentJournal of Molecular and Cellular Cardiology, 1983
- CIRCUMVENTION OF VINCRISTINE AND ADRIAMYCIN RESISTANCE INVITRO AND INVIVO BY CALCIUM INFLUX BLOCKERS1983
- POTENTIATION OF VINCRISTINE AND ADRIAMYCIN EFFECTS IN HUMAN HEMATOPOIETIC TUMOR-CELL LINES BY CALCIUM-ANTAGONISTS AND CALMODULIN INHIBITORS1983
- INCREASED ACCUMULATION OF VINCRISTINE AND ADRIAMYCIN IN DRUG-RESISTANT P388-TUMOR CELLS FOLLOWING INCUBATION WITH CALCIUM-ANTAGONISTS AND CALMODULIN INHIBITORS1982
- EFFECT OF VITAMIN-E AGAINST ADRIAMYCIN-INDUCED TOXICITY IN RABBITS1980
- Sequestration of 45Ca2+ by mitochondria from rabbit heart, liver, and kidney after doxorubicin or digoxin/doxorubicin treatmentExperimental and Molecular Pathology, 1979
- ACTIVE EFFLUX OF DAUNORUBICIN AND ADRIAMYCIN IN SENSITIVE AND RESISTANT SUBLINES OF P388-LEUKEMIA1979
- MECHANISM OF CROSS-RESISTANCE BETWEEN VINCRISTINE AND DAUNORUBICIN IN EHRLICH ASCITES TUMOR-CELLS1978
- ELECTROLYTE AND MORPHOLOGIC ALTERATIONS OF MYOCARDIUM IN ADRIAMYCIN-TREATED RABBITS1974